Progression of IgA gammopathy to myeloma following infliximab treatment for pyoderma gangrenosum

被引：12
|
作者：
Shareef, M. S. [1 ]
Munro, L. R. [2 ]
Owen, R. G. [3 ]
Highet, A. S. [1 ]
机构：
[1] York Teaching Hosp, Dept Dermatol, York, N Yorkshire, England
[2] York Teaching Hosp, Dept Haematol, York, N Yorkshire, England
[3] St James Univ Hosp, HMDS Lab, Leeds, W Yorkshire, England
来源：
CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2012年 / 37卷 / 02期
关键词：
MULTIPLE-MYELOMA; MONOCLONAL GAMMOPATHY; CRITERIA;
D O I：
10.1111/j.1365-2230.2011.04219.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Pyoderma gangrenosum (PG) may be associated with inflammatory disorders and haematological conditions such as monoclonal gammopathy of uncertain significance (MGUS). We report the case of a 53-year old man who had PG and MGUS. After treatment with infliximab for the PG, he developed myeloma. The course of events in this case suggests that infliximab facilitated the progression from MGUS to myeloma.
引用
收藏
页码：146 / 148
页数：3
相关论文
共 50 条
  • [1] Pyoderma Gangrenosum in a Patient with Multiple Myeloma
    Kikuchi, Yuji
    Yoshimi, Mayumi
    Takahashi, Tsuyoshi
    INTERNAL MEDICINE, 2016, 55 (06) : 711 - 711
  • [2] Multiple myeloma associated with IgA lambda gammopathy and multiple myeloma oncogene 1 in a Yorkshire terrier
    Kim, S.
    Son, E.
    Lee, S.
    Lee, S.
    Kim, H.
    Kang, M.
    Lee, C.
    Park, H.
    VETERINARNI MEDICINA, 2018, 63 (04) : 187 - 192
  • [3] Pyoderma gangrenosum following hematopoietic stem cell transplantation
    Eddou, H.
    Ennouhi, A.
    Sina, M.
    Zinebi, A.
    El Benaye, J.
    Moudden, M. K.
    Doghmi, K.
    Malfuson, J-, V
    Mikdame, M.
    El Baaj, M.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2018, 145 (6-7): : 445 - 450
  • [4] Dramatic resolution of disseminated pyoderma gangrenosum associated with monoclonal gammopathy after therapy with bortezomib and dexamethasone
    Velasco-Tamariz, Virginia
    Carreno-Tarragona, Gonzalo
    Tous-Romero, Fatima
    Gil-de la Cruz, Elena
    Martin-Clavero, Estela
    Rivera-Diaz, Raquel
    INTERNATIONAL WOUND JOURNAL, 2017, 14 (06) : 1382 - 1384
  • [5] Generalized Acquired Cutis Laxa Associated With Multiple Myeloma With Biphenotypic IgG-λ and IgA-κ Gammopathy Following Treatment of a Nodal Plasmacytoma
    New, H. Douglas
    Callen, Jeffrey P.
    ARCHIVES OF DERMATOLOGY, 2011, 147 (03) : 323 - 328
  • [6] Acupuncture-exacerbated Pyoderma Gangrenosum Associated With IgG Multiple Myeloma br
    Lyu, Jiajie
    Wang, Sun
    Zhang, Hanshuo
    Liu, Shengxiu
    WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2022, 34 (11): : E108 - E111
  • [7] Timing of treatment of smoldering myeloma: delay until progression
    Kumar, Shaji K.
    BLOOD ADVANCES, 2018, 2 (21) : 3050 - 3053
  • [8] Monoclonal gammopathy of undetermined significance related pyoderma gangrenosum successfully treated with autologous peripheral blood stem cell transplantation
    Chang, Ching-Ming
    Hwang, Wen-Lee
    Hsieh, Zu-Yi
    Wang, Ren-Ching
    Teng, Chieh-Lin
    ANNALS OF HEMATOLOGY, 2010, 89 (08) : 823 - 824
  • [9] Updates on mechanisms of disease progression in precursor myeloma: Monoclonal gammopathy of undermined significance and smoldering myeloma
    Saade, Cynthia
    Ghobrial, Irene M.
    PRESSE MEDICALE, 2025, 54 (01):
  • [10] Acquired cutis laxa following urticarial vasculitis associated with IgA myeloma
    Turner, Ryan B.
    Haynes, Harley A.
    Granter, Scott R.
    Miller, Danielle M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (06) : 1052 - 1057
12345